As Senate Gears Up For Kavanaugh Fight, Poll Finds 71% Of Voters Oppose Overturning Roe V. Wade
And nearly 60 percent of them feel strongly about their opinion, according to the Wall Street Journal/NBC News survey. Supreme Court nominee Brett Kavanaugh has been looked at by anti-abortion advocates as their best hope in years for overturning Roe v. Wade.
The Wall Street Journal:
Record 71% Of Voters Oppose Overturning Roe V. Wade
As the Senate nears debate on a new Supreme Court nominee who could give the panel a conservative edge, a majority of voters say they are increasingly opposed to undermining a woman’s right to have an abortion and are becoming more likely to say they support abortion-rights candidates, a new poll shows.According to a Wall Street Journal/NBC News poll, Mr. Trump’s latest pick for the High Court, Brett Kavanaugh, enters confirmation proceedings with support from 32% of voters, compared with 26% opposed. Another 41% said they don’t have enough information yet. (Bender, 7/23)
In other national health care news —
The Associated Press:
Administration Reports Nearly 1,200 Family Reunifications
Nearly 1,200 children 5 and older have been reunited with their families after being separated at the U.S.-Mexico border, leaving hundreds to go before this week's court-imposed deadline, according to a Justice Department court filing on Monday that raised the possibility that many parents have been deported. (7/23)
Americans Skeptical Of Trump’s Drug Plan — If They’ve Even Heard Of It
President Donald Trump was hoping for a big win with voters when he rolled out a massive blueprint to lower drug prices in May. But two months later, most Americans haven’t even heard about it, a new poll shows. And few of the Americans who are aware of his plan believe it will lower drug prices. (Karlin-Smith and Ehley, 7/23)
The New York Times:
For Scientists Racing To Cure Alzheimer’s, The Math Is Getting Ugly
The task facing Eli Lilly, the giant pharmaceutical company, sounds simple enough: Find 375 people with early Alzheimer’s disease for a bold new clinical trial aiming to slow or stop memory loss. There are 5.4 million Alzheimer’s patients in the United States. You’d think it would be easy to find that many participants for a trial like this one. But it’s not. And the problem has enormous implications for treatment of a disease that terrifies older Americans and has strained families in numbers too great to count. (Kolata, 7/23)
Antibiotic-Resistant Infections Began After Surgery. Were They Transmitted By Leeches?
When doctors saw blood pooling in the new graft, threatening to kill this one, too, they had the perfect treatment. Down in a hospital lab was a tank rippling with leeches. They fished some out and placed them on the man’s face. Things got better for Christmas. For New Year’s, they got worse. The wound had started oozing pus, which smelled like a sewer and baffled the physicians. Leech guts, like ours, are crawling with bacteria, so the team had pumped the patient full of ciprofloxacin before allowing his blood to be sucked. That should have stopped any infections before they started. Then lab tests confirmed their suspicions: These bugs, called Aeromonas, were cipro-resistant. (Boodman, 7/24)